{"data":{"id":"us/21-cfr-200.51","jurisdiction":"us","citation":"21 CFR 200.51","heading":"Aqueous-based drug products for oral inhalation.","body":"(a) All aqueous-based drug products for oral inhalation must be manufactured to be sterile.\n(b) Manufacturers must also comply with the requirements in § 211.113(b) of this chapter.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER C—DRUGS: GENERAL","PART 200—GENERAL","Subpart C—Requirements for Specific Classes of Drugs"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"f03ac99ba604d3853a0915549b37439e7338af040af24555571ac3035db97f66","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-200.50","next":"us/21-cfr-200.200"},"notice":"GroundRules: Original legal text. Not legal advice."}